What's breaking now, across thousands of outlets.
(MedPage Today) -- Overall survival (OS) in extensive-stage small-cell lung cancer (ES-SCLC) approached 2 years with tarlatamab (Imdelltra) combination maintenance therapy after first-line chemoimmunotherapy, a large randomized trial showed. Median...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Betsi Cadwaladr health board was due to pay Bangor University £110,686 for two researchers.
(MedPage Today) -- DENVER -- Treatment with SGLT2 inhibitors was linked with modest but statistically significant increases in hemoglobin and hematocrit levels across a broad spectrum of patient…
Exclusive: People from marginalised groups more likely to be diagnosed via urgent referral or in emergency setting, research finds People from minority ethnic backgrounds in England are up to a third…
VATICAN CITY, Oct 25 (Reuters) - Pope Leo called for an end to the violence in Yemen on Sunday, as he addressed the faithful from the window over St Peter's Square less than two weeks after having…
Uganda has discharged 60 people who had been monitored for possible exposure to Ebola after they completed the mandatory 21-day observation period without developing symptoms, Health Minister Chris…
